BioMarin Pharmaceutical Inc.

BM8.F·Frankfurt
Compare
49.40−1.02 (−2.02%)today
As of Oct 22, 1:27 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close50.42
Open48.96
Day range48.9649.40
52-week range42.6260.74
Off day high0.00%
Off 52-week high−18.67%
Volume94.00
Avg. volume (3M)154
Market cap9.56B
EPS (TTM)0.3200
Forward P/E53.70
P/E ratio (TTM)154.38
Dividend yield—
Beta (5Y)—
Shares outstanding193.57M
Short interest—
Earnings dateAug 6, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
BM8.F BBIO IONS 1952.HK ZEAL.CO KRYS
Market cap 9.56B 13.32B 7.30B 12.02B 15.35B 9.48B
P/E (TTM) 154.4 — — — 6.0 40.1
Forward P/E 53.7 -303.3 -38.3 24.9 32.4 35.8
Price/book 1.7 -5.3 16.5 1.6 0.9 7.0
Dividend yield — — — — — —
1-year change +10.06% +25.89% −38.08% −26.08% −50.15% +72.79%
Today −2.02% +0.56% −0.81% −5.77% −0.13% −0.63%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All BM8.F news ›
Star Tribune·Positive

Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today

Shares of biotech company BioMarin Pharmaceutical (NASDAQ: BMRN) jumped 3.3% in the afternoon session after the company agreed to acquire Alesta Therapeutics, a clinical-stage biotech company. According to a company press release, BioMarin…

Markets Daily·Positive

BioMarin Pharmaceutical (NASDAQ:BMRN) Now Covered by UBS Group

Posted by Michael Walen on Oct 15th, 2026 Stock analysts at UBS Group initiated coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “buy” rating and a…

From articles in the 4Search news index.

In the news

11mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.